1.
Rev Esp Anestesiol Reanim (Engl Ed)
; 69(9): 592-596, 2022 11.
Article
in English
| MEDLINE | ID: covidwho-2061811
ABSTRACT
Co-infections between SARS-CoV-2 and other pathogens is an important consideration for the treatment of patients with COVID-19. Aspergillus infections are part of this consideration since they present high morbidity and mortality. We present the case of a patient with COVID-19 and Aspergillus Fumigatus coinfection that evolves with brain death due to multiple heterogeneous lesions in the brain, which after a post-mortem biopsy found pathological lesions compatible with Aspergillus.